WHO guidelines conditionally endorse long-term GLP-1 therapy for obesity, emphasizing lifestyle modifications and addressing affordability and access challenges. GLP-1 therapies are included in the ...

Share on Pinterest The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy New guidelines from the World Health Organization (WHO) ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the way the U.N. agency has historically framed obesity treatment. The WHO ...

The WHO has just released landmark global guidelines recommending for the first time that GLP-1 medicines may be used for long-term treatment of obesity in adults. The move comes as obesity rates ...

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...

The World Health Organization issued new guidelines Monday recommending the use of GLP-1 drugs for treating obesity. In the new guidelines, the United Nations health agency made two key ...

The European Association for the Study of Obesity recommends the GLP-1 injectables semaglutide and tirzepatide as first-line treatments for most cases of obesity. This is due to their higher efficacy ...

UK experts are warning that access to new weight-loss drugs could depend more on wealth than medical need. Strict NHS ...

Experts say the official recommendation reemphasizes the game-changing ability of GLP-1 medications, but stress that diet and exercise are integral to an effective treatment plan for obesity. The ...